G. Wilson

Degenerative Disc Disease VAST Clinical Trial: Safely Supplementing Tissue Lost to

Douglas P. Beall, G. Wilson, R. Bishop, 2020 .

Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor–Induced Angioedema

C. M. Culley, Colleen M. Culley, G. Wilson, 2016, The Annals of pharmacotherapy.

Viable Disc Tissue Allograft Supplementation; One- and Two-level Treatment of Degenerated Intervertebral Discs in Patients with Chronic Discogenic Low Back Pain: One Year Results of the VAST Randomized Controlled Trial.

K. Amirdelfan, M. Lorio, T. Ganey, 2021, Pain physician.

VAST Clinical Trial: Safely Supplementing Tissue Lost to Degenerative Disc Disease

D. Beall, G. Wilson, R. Bishop, 2020, International Journal of Spine Surgery.